Although biomarkers such as procalcitonin (PCT), interleukin-6 (IL-6), and C-reactive protein (CRP) have been extensively studied for the diagnosis of infection and sepsis [8,9,10,11,12,13], their clinical performance in immunosuppressed patients remains less clearly defined [14]. This evidence concerns the gene IL6 and infection.